Literature DB >> 16440000

Two internal ribosome entry sites mediate the translation of p53 isoforms.

Partho Sarothi Ray1, Richa Grover, Saumitra Das.   

Abstract

The p53 tumour suppressor protein has a crucial role in cell-cycle arrest and apoptosis. Previous reports show that the p53 messenger RNA is translated to produce an amino-terminal-deleted isoform (DeltaN-p53) from an internal initiation codon, which acts as a dominant-negative inhibitor of full-length p53. Here, we show that two internal ribosome entry sites (IRESs) mediate the translation of both full-length and DeltaN-p53 isoforms. The IRES directing the translation of full-length p53 is in the 5'-untranslated region of the mRNA, whereas the IRES mediating the translation of DeltaN-p53 extends into the protein-coding region. The two IRESs show distinct cell-cycle phase-dependent activity, with the IRES for full-length p53 being active at the G2-M transition and the IRES for DeltaN-p53 showing highest activity at the G1-S transition. These results indicate a novel translational control of p53 gene expression and activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440000      PMCID: PMC1456917          DOI: 10.1038/sj.embor.7400623

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  22 in total

1.  Identification and characterization of a novel cell cycle-regulated internal ribosome entry site.

Authors:  S Cornelis; Y Bruynooghe; G Denecker; S Van Huffel; S Tinton; R Beyaert
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

Review 2.  Internal ribosome entry sites in eukaryotic mRNA molecules.

Authors:  C U Hellen; P Sarnow
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

Review 3.  Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites.

Authors:  S Vagner; B Galy; S Pyronnet
Journal:  EMBO Rep       Date:  2001-10       Impact factor: 8.807

4.  Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray.

Authors:  G Johannes; M S Carter; M B Eisen; P O Brown; P Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

5.  DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53.

Authors:  Stéphanie Courtois; Gerald Verhaegh; Sophie North; Maria-Gloria Luciani; Patrice Lassus; Ula Hibner; Moshe Oren; Pierre Hainaut
Journal:  Oncogene       Date:  2002-10-03       Impact factor: 9.867

6.  p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.

Authors:  Yili Yin; C W Stephen; M Gloria Luciani; Robin Fåhraeus
Journal:  Nat Cell Biol       Date:  2002-06       Impact factor: 28.824

7.  Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin.

Authors:  Masatoshi Takagi; Michael J Absalon; Kevin G McLure; Michael B Kastan
Journal:  Cell       Date:  2005-10-07       Impact factor: 41.582

8.  Nucleolin stimulates viral internal ribosome entry site-mediated translation.

Authors:  R E Izumi; B Valdez; R Banerjee; M Srivastava; A Dasgupta
Journal:  Virus Res       Date:  2001-07       Impact factor: 3.303

9.  Ribosomal protein S5 interacts with the internal ribosomal entry site of hepatitis C virus.

Authors:  S Fukushi; M Okada; J Stahl; T Kageyama; F B Hoshino; K Katayama
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

Review 10.  Tumor suppressor p53: regulation and function.

Authors:  K Somasundaram
Journal:  Front Biosci       Date:  2000-04-01
View more
  97 in total

1.  Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita.

Authors:  Cristian Bellodi; Noam Kopmar; Davide Ruggero
Journal:  EMBO J       Date:  2010-05-07       Impact factor: 11.598

2.  Reversible induction of translational isoforms of p53 in glucose deprivation.

Authors:  D Khan; A Katoch; A Das; A Sharathchandra; R Lal; P Roy; S Das; S Chattopadhyay; S Das
Journal:  Cell Death Differ       Date:  2015-02-27       Impact factor: 15.828

Review 3.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

Review 4.  Posttranscriptional regulation of p53 and its targets by RNA-binding proteins.

Authors:  Jin Zhang; Xinbin Chen
Journal:  Curr Mol Med       Date:  2008-12       Impact factor: 2.222

5.  Quantifying the dynamics of IRES and cap translation with single-molecule resolution in live cells.

Authors:  Amanda Koch; Luis Aguilera; Tatsuya Morisaki; Brian Munsky; Timothy J Stasevich
Journal:  Nat Struct Mol Biol       Date:  2020-09-21       Impact factor: 15.369

6.  Amino-terminal p53 mutations lead to expression of apoptosis proficient p47 and prognosticate better survival, but predispose to tumorigenesis.

Authors:  Beng Hooi Phang; Rashidah Othman; Gaelle Bougeard; Ren Hui Chia; Thierry Frebourg; Choong Leong Tang; Peh Yean Cheah; Kanaga Sabapathy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

Review 7.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

8.  A gene signature-based approach identifies mTOR as a regulator of p73.

Authors:  Jennifer M Rosenbluth; Deborah J Mays; Maria F Pino; Luo Jia Tang; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

9.  Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.

Authors:  Matteo Rossi; Oleg N Demidov; Carl W Anderson; Ettore Appella; Sharlyn J Mazur
Journal:  Nucleic Acids Res       Date:  2008-11-10       Impact factor: 16.971

10.  Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells.

Authors:  Stéphane Belin; Anne Beghin; Eduardo Solano-Gonzàlez; Laurent Bezin; Stéphanie Brunet-Manquat; Julien Textoris; Anne-Catherine Prats; Hichem C Mertani; Charles Dumontet; Jean-Jacques Diaz
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.